Mednax (MD) PT Raised to $62 at Stephens; Reiterates Overweight
Tweet Send to a Friend
Stephens raised its price target on Mednax (NYSE: MD) to $62.00 (from $55.00) while maintaining a Overweight rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
